Advances in viral-vector systemic cytokine gene therapy against cancer

Area of Science:

• Oncology
• Immunology
• Gene Therapy

Background:

• Current cancer gene therapy focuses on inhibiting tumor growth and activating host defenses.
• Cytokine gene-transduced tumor cells have been explored as vaccines, demonstrating safety and local responses but limited systemic efficacy.

Purpose of the Study:

• To review current achievements in cytokine gene therapy for cancer treatment, focusing on viral-vector approaches.
• To discuss challenges and propose future directions for enhancing immune stimulation and systemic efficacy.

Main Methods:

• Review of existing clinical trial data and scientific literature on cytokine gene therapy.
• Analysis of viral-vector strategies for gene delivery and cytokine expression.

Main Results:

• Cytokine gene therapy shows good safety profiles and local tumor responses.
• Substantial lack of systemic efficacy remains a key limitation in current approaches.

Conclusions:

• Optimizing cytokine gene selection and delivery is crucial for improving immune stimulation.
• Future research should focus on achieving efficient and durable cytokine expression for enhanced systemic anti-cancer effects.